Key Market Indicators
Demand for diagnostic reagents in Norway is set to reach $202 million by 2026, growing by an average of 1.1% each year. This figure was $189 million in 2021 and has grown by 2.1% annually since 1998. Norway was in 32nd place in 2021, with the Czech Republic ahead of it on $189 million. Germany, China and the Netherlands were respectively in 2nd, 3rd and 4th place in this ranking. Supply of diagnostic reagents in Norway is set to reach $275 million by 2026, increasing by an average of 2.6% each year. This figure was $233 million in 2021 and has risen by 7.8% annually since 1998. Norway was in 20th place in 2021, with Austria ahead of it on $233 million. Germany, the Netherlands and the United Kingdom were respectively in 2nd, 3rd and 4th places in this ranking.
